Topeka ? A company that provides a fat-dissolving injection called Lipodissolve is contesting a state board’s decision to restrict the procedure in Kansas.

The Kansas State Board of Healing Arts ruled on Aug. 18 that Lipodissolve can’t be dispensed unless it is authorized by a doctor as part of an investigational drug trial.

Fig, based in St. Louis, filed a petition for review Friday in Shawnee County District Court, seeking a temporary restraining order to prevent implementation of that decision, which is scheduled to take effect Sept. 14.

Fig, formerly known as Advanced Lipo Dissolve, operates a clinic in Overland Park. Company officials said they support requiring a physician to authorize use of Lipodissolve but don’t want the procedure limited to drug trials.

“We regret that the board’s recent ruling has led to this effort yet remain hopeful that the board will provide itself the additional time and opportunity to discuss and consider the totality of evidence available to make an informed decision,” Rob Semaan, Fig’s chief executive officer, said in a statement.

Larry Buening, the board’s executive director, said “we believe the board’s action was appropriate and proper.”

The board’s decision was the first of its kind in the country. It covers the most common form of Lipodissolve, which involves injections to remove fatty deposits in certain areas that don’t respond to diet and exercise. The treatment has not been approved by the Food and Drug Administration.

Mark Stafford, the board’s general counsel, said earlier that the board had received at least half a dozen complaints about the procedure, including side effects such as nodules, infections and nausea.

It is not clear how many Kansas businesses will be affected by the new restrictions. Stafford has said the board did not have know how many Kansans have received the injections or the number of Kansas facilities that administer Lipodissolve.